Sickle cell disease: a chronic inflammatory condition

2001 ◽  
Vol 57 (1) ◽  
pp. 46-50 ◽  
Author(s):  
J.A.B. Chies ◽  
N.B. Nardi
2019 ◽  
Vol 25 ◽  
pp. 107602961982883 ◽  
Author(s):  
Asmaa M. Zahran ◽  
Khalid I. Elsayh ◽  
Khaled Saad ◽  
Mostafa M. Embaby ◽  
Mervat A. M. Youssef ◽  
...  

Sickle cell disease (SCD) is a genetically inherited hemolytic anemia increasingly appreciated as a chronic inflammatory condition and hypercoagulable state with high thrombotic risk. It is associated with disturbed immune phenotype and function and circulating microparticles (MPs) derived from multiple cell sources. This study was carried out to determine MPs profiles in patients with sickle cell anemia (either on hydroxyurea (HU) therapy or those with no disease-modifying therapy) and to compare these profiles with healthy children. Moreover, our study assesses the potential impact of HU on other aspects of circulating MPs. We performed a cross-sectional study on 30 pediatric patients with SCD divided by treatment into 2 groups (those receiving HU or no therapy) attending Hematology Clinic and 20 age-matched healthy children. The blood samples obtained were analyzed for MPs by flow cytometry. Sickle cell disease group with no therapy showed elevated levels of total, platelet, and erythroid MPs. In contrast, therapy with HU was associated with normalization of MPs. This study provided additional evidence that HU is an effective treatment option in pediatric patients with SCD, as it seems that it decreases the abnormally elevated MPs in those patients.


Blood ◽  
2014 ◽  
Vol 124 (21) ◽  
pp. 4910-4910 ◽  
Author(s):  
Simone CO Gilli ◽  
Fernando V Pericole ◽  
Bruno Deltreggia Benites ◽  
Lilian Castilho ◽  
Marcelo Addas-Carvalho ◽  
...  

Abstract Sickle cell disease (SCD) is a chronic inflammatory condition, even in steady state, as indicated by elevated levels of inflammatory cytokines and increased Th17 responses, compared with healthy controls. These inflammatory pathways may be directly regulated by genetic polymorphisms and could be associated to different outcomes of the disease. High levels of a number of different circulating cytokines were found in SCD patients in several studies, and changes in the cytokine balance in SCD patients are an important risk factor for the occurrence of clinical events. Moreover, inter-patient variations in cytokine levels could be attributed to gene polymorphisms. To investigate cytokine polymorphisms and their association with cytokines expression we evaluated the IL4 intron3 VNTR (genotypes 1.1, 1.2, 2.2, 2.3), IL4T590C/T, IL6174G/C and TNFA308A/G polymorphisms and their correlation with TGFB, IL-4, IL-6 and IL-10 expression in steady-state SCD patients. Methods. Fourth-nine patients (24 male and 25 female; 39.8 ± 9.59 years) with SCD and 28 (22 male and 6 female; 35.5 ± 10.2 years) healthy blood donors were evaluated. The polymorphisms were performed by PCR-RFLP analysis described as [individuals (genotype frequencies)] and the expression of TGFB, IL-4, IL-6 and IL-10 by q-PCR expressed as [median (max-min)]. Results. A higher frequency of 1.2, 2.2 and 2.3 genotypes was found in SCD patients compared with normal controls [34(0.69) vs 12 (0.44), P=0.03]; higher expression of IL-4 was found in the ones carrying the 1.1 genotype [0.31 (2.53-0.01) vs 0.05 (0.95-0.0), P=0.047] and although no differences were found in the IL4T590C/T, IL6174G/C and TNFA308A/G polymorphism frequencies, a significantly greater expression of TGFB, IL6 and IL10 was observed in the patients cohort compared to normal individuals [1.55 (9.02-0.0) vs 0.97 (5.46-0.0), P=0.019]; [0.18 (45.45-0.0) vs 0.0 (8.14-0.0), P=0.03] and [0.98 (22.84-0.0) vs 0.0 (9.95-0.0), P<0.001, respectively]. All the genotype frequencies are consistent with Hardy-Weinberg equilibrium. Conclusion: A unique distribution of IL-4 genotypes was observed in our cohort of patients and controls, probably related to the miscellaneous ethnic background of our population. The highest prevalence of the IL4intron3 polymorphism in sickle cell patients suggests a less secretory phenotype associated with increased expression of inflammatory cytokines. IL-4 plays an important role in tissue adhesion and inflammation, including induction of adhesion molecules on vascular endothelial cells and could be responsible for a more “inflammatory” phenotype. Despite the small number of patients enrolled, our study brings insights and new data regarding the deregulation in immune system affecting SCD patients and this information must be investigated in larger cohorts, and may help to better characterize individual variations in immune responses and new markers for disease morbidity. Disclosures No relevant conflicts of interest to declare.


Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 2343-2343
Author(s):  
Nicola Conran ◽  
Carolina Lanaro ◽  
Fernanda G. Pereira ◽  
Tohru Ikuta ◽  
Sara T.O. Saad ◽  
...  

Abstract Sickle cell disease (SCD) is now widely regarded as a chronic inflammatory condition, characterized by high base-line leukocyte counts, alterations in inflammatory cytokine levels, vascular endothelial injury and increased red and white cell adhesiveness. We hypothesized that this inflammatory state may be exacerbated by alterations in the apoptotic process in inflammatory cells, such as neutrophils. Neutrophils were isolated from the peripheral blood of healthy controls and individuals with SCD in steady state by separation over a ficoll-paque gradient. Following washing and lysis of contaminating red cells, neutrophils were cultured in DMEM supplemented with 10% (v/v) autologous serum and antibiotics for 20 h (4 x 106 cells/ml, 37oC, 5% CO2). Apoptosis was assessed by flow cytometry using a fluorescein isocyanate-labeled recombinant annexin V antibody and propidium iodide staining. Morphological analysis confirmed the apoptotic state of cells. After 20 h in culture, the percentage of non-apoptotic neutrophils from SCD patients (SCD neutrophils; 13.34 ± 1.03 %, n=8) was significantly higher than the percentage of non-apoptotic normal neutrophils (7.68 ± 1.59, n=7; P&lt;0.01). Apoptosis is mediated by a number of signaling pathways, with the cAMP-dependent pathway being known to have an important anti-apoptotic role in neutrophils. Accordingly, measurement of cAMP in isolated normal and SCD neutrophils by ELISA demonstrated levels of cAMP to be significantly increased in the neutrophils of SCD individuals (4.55 ± 0.38 pMol/1x 106 cells compared to 2.18 ± 0.39 pMol/1x 106 cells in normal individuals, n&gt;14, P&lt;0.001). Co-incubation of SCD neutrophils during 20h-culture with a cAMP-dependent protein kinase (PKA) inhibitor, KT5720 (3μM), significantly decreased the percentage of non-apoptotic cells (12.88 ± 1.49 %, decreased to 6.18 ± 0.51 %, n=6; p=0.01) to levels similar to those seen in normal neutrophil cultures, indicating that the anti-apoptotic effect seen in SCD neutrophils is probably mediated by a cAMP-PKA dependent mechanism. Interestingly, when SCD neutrophils were cultured in medium containing fetal calf serum instead of autologous serum, the number of non-apoptotic cells at 20 h of culture was not different to the number of normal non-apoptotic neutrophils (8.91 ± 2.55 % compared to 9.08 ± 2.11 %, respectively, n= 7, P&gt;0.05). This finding may indicate that this anti-apoptotic effect may be maintained by survival factors contained in serum; indeed incubation of normal neutrophils with SCD patient serum (10 % v/v, 30 min, 37oC), but not control serum, significantly augmented intracellular cAMP levels by 117.9 ± 10.5 % (n=8, p&lt;0.01). In conclusion, we have observed an increased survival of neutrophils from SCD individuals under culture conditions, probably mediated by an up-regulated cAMP-PKA pathway and possibly dependent on cAMP-elevating survival factors contained in the serum. Since neutrophil apoptosis is imperative for the resolution of inflammation, increased neutrophil survival may be an important contributing factor to the chronic inflammatory state that characterizes SCD.


1974 ◽  
Vol 133 (4) ◽  
pp. 624-631 ◽  
Author(s):  
T. A. Bensinger

2020 ◽  
Vol 8 (4) ◽  
pp. 390-401 ◽  
Author(s):  
Taryn M. Allen ◽  
Lindsay M. Anderson ◽  
Samuel M. Brotkin ◽  
Jennifer A. Rothman ◽  
Melanie J. Bonner

Sign in / Sign up

Export Citation Format

Share Document